In this in-person, interactive roundtable event in NYC, co-organized by Mongabay, the Committee to Protect Journalists and the Society of Environmental Journalists, Mongabay's award-winning reporter (and SEJ board member) Karla Mendes will be in conversation with the Committee to Protect Journalists on how to bridge local-to-global coverage on the road to COP30. 3:30 - 5 p.m. EDT.
"A recent study has revealed that the majority of shark meat available to American shoppers is mislabeled, with much of it coming from endangered species."
"Big Tech’s AI frenzy is pressing up electricity demand around the country. The power grid is stuck in natural gas-fuelled inertia, slow to bring new clean energy projects online and leaving consumers on the hook."
"Rising temperatures have caused as many as 4.6 million extra dengue cases each year, and will cause many more by 2050, a new study finds."
"A growing population, leaking pipes and changing climate threaten the state’s water supply. Texas lawmakers hope a $20 billion investment will help."
"In the most remote parts of Alaska, staying in touch can involve a bit more effort than sending a text. Cell service is spotty, highways are nonexistent, and the postal service remains a vital lifeline, delivering supplies and mail by plane. But for anyone who wants to broadcast a different kind of message — a reminder to pick up milk, for example, or birthday wishes — there’s always the Muktuk Telegram."
"USDA’s staffing cuts, scuttled conservation programs, and misdirected crop insurance are hitting farmers hard."
"A group of experts says Western states urgently need to cut water use to avert a deepening crisis on the Colorado River. The river’s major reservoirs are less than one-third full, and another dry winter would push reservoirs toward critically low levels."
"Both House and Senate lawmakers have advanced bills rejecting the Trump administration’s proposal to eliminate climate research at the weather agency."
"FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny."
